Cost impact of procalcitonin-guided decision making on duration of antibiotic therapy for suspected early-onset sepsis in neonates.
Alexandra J L M GeraerdsWendy van HerkMartin StockerSalhab El HelouSourabh DuttaMatteo S FontanaFrank A B A SchuermanRita K van den Tooren-de GrootJantien WieringaJan JanotaLaura H van der Meer-KappelleRob MoonenSintha D SieEsther de VriesAlbertine E DonkerUrs ZimmermanLuregn J SchlapbachAmerik C de MolAngelique Hoffman-HaringsmaMadan RoyMaren TomaskeRené F KornelisseJuliette van GijselEline G VisserAnnemarie M C van RossumSuzanne PolinderPublished in: Critical care (London, England) (2021)
Health care costs of PCT-guided decision making of term and late-preterm neonates with suspected EOS are not significantly different from costs of standard care. Significant cost reduction was found for risk category 'infection unlikely,' and is affected by both the price of PCT-testing and (prolonged) hospitalization due to SAEs.